Careverse CoronaryDoc is a web-based tool for trained medical professionals to view and analyze CCTA CT data for coronary plaques and stenosis, with coronary measurements, visualization, automated plaque and stenosis outputs, and structured reporting for physician review.
Evidence status: each field shows source quality, applicability, and review date. Research pending, information not established in reviewed sources, and vendor documentation pending are distinct outcomes.
Clinical fit
What this tool is for
Start with the authorized purpose, then verify how it fits your service line and reading workflow.
Exact purpose
Careverse CoronaryDoc is a web-based tool for trained medical professionals to view and analyze CCTA CT data for coronary plaques and stenosis, with coronary measurements, visualization, automated plaque and stenosis outputs, and structured reporting for physician review.
FDA source Exact FDA submission Checked 2026-09-07
Web-based post-processing, coronary measurement and visualization, automated plaque and stenosis analysis, and structured report preparation for physician review.
FDA source Exact FDA submission Checked 2026-09-07
The software is not intended to replace qualified practitioner judgment and requires trained users. The reported agreement values are table-specific regulatory results, not a product-wide diagnostic sensitivity or clinical-outcome claim.
FDA source Exact FDA submission Checked 2026-09-07
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
FDA submission
K251656
FDA source Exact FDA submission Checked 2026-08-31
Use these fields to structure a vendor demo, security review, and implementation estimate.
Integration
The FDA summary describes a web application with DICOM CT input, transmission queues, image management, editing, and structured reports; local PACS, RIS, identity, routing, and report-ingestion behavior require testing.
FDA source Exact FDA submission Checked 2026-09-07
K251656 describes a web-based application; public material reviewed does not establish hosting region, PHI flow, retention, availability, or site-specific service boundaries.
FDA source Exact FDA submission Checked 2026-09-07
The exact submission is a web-based application for CCTA CT post-processing, coronary measurement, automated plaque and stenosis analysis, and structured reporting.
Careverse lists CoronaryDoc in its Digital Heart family alongside coronary FFR, calcium-score, cardiac-function, and plaque-analysis applications; the page presents family context rather than K251656 release documentation.
Test DICOM import, identity mapping, series selection, routing, structured-report delivery, user roles, edits, and failure recovery with the installed version before clinical use.
exact submission · checked 2026-09-07
This is buyer acceptance guidance based on the FDA-described workflow, not a verified interface contract.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version.
Evidence summary
K251656 FDA evidence is a manufacturer-submitted regulatory agreement package for coronary stenosis and plaque outputs; the stored literature and trial candidate arrays were empty and no independent study was promoted.
FDA source Exact FDA submission Checked 2026-09-07
K251656 Careverse CoronaryDoc stenosis and plaque performance tables
Retrospective regulatory agreement testing against labeled/reference measurements across stenosis grades and plaque-volume outputs. · CCTA cardiac CT measurements for CAD or suspected CAD
exact submission · Tested version: Careverse CoronaryDoc configuration described in K251656 · Sponsor or vendor study
K251656
Measurement counts are reported by grade in the FDA table; unique patient and site counts are not promoted.
These are common procurement questions; unknown values remain visible until a source supports them.
Pricing and total cost
Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-07
No public list price or contract unit for K251656 was established in the reviewed official sources.
Reimbursement and coding
CMS LCD L39913 v7 and Article A59813 v6 provide conditional service-level policy context for AI-QCT/AI-CPA after completed and interpreted CCTA in WPS Medicare J5/J8 for selected symptomatic chest-pain patients; exact product/version eligibility and individual claim eligibility are not established.
Public source Product family Checked 2026-09-07
Service-level policy context; exact product/version and individual claim eligibility are not established. This is not a product code assignment, universal Medicare coverage determination, fee, or price.
Medicare / WPS · United States - WPS J5/J8 jurisdictions · Effective 2026-01-01
CMS policy context applies to an eligible CCTA plaque-analysis service in a limited WPS policy scope; it does not assign coverage to K251656 or establish individual claim eligibility.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
The wave22 exact-submission recall query returned no native recall record for K251656. This does not establish absence of family, later-version, or adverse-event information.
Public source Exact FDA submission Checked 2026-09-07
Verify security and privacy controls: The reviewed exact FDA packet and Careverse family page do not establish a current scoped security attestation or deployed data-flow controls.
Verify pricing and total cost: No public list price or contract unit for K251656 was established in the reviewed official sources.
This audit distinguishes completed source review from fields that have not yet been researched.
Human reviewedStatus
2026-09-07Last searched
24Fields reviewed
12Source classes checked
0Reviewed PubMed leads
0Reviewed trial leads
0Unreviewed FDA recall leads
The stored PubMed and ClinicalTrials.gov candidate arrays were screened and were empty. No paper or trial was promoted; empty stored arrays do not establish that no external literature or trials exist. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, vendor product page, payer policy, fda device recall, literature index, trial registry, stored candidate metadata, pubmed, clinical trials, openfda device recall
cvi42 Coronary Plaque supports qualified professionals with viewing, post-processing, and qualitative and quantitative evaluation of adult cardiac CT DICOM images to assess the...
PRAEVAorta 2 assists clinical specialists, physicians, and other licensed practitioners with automatic vascular segmentation and maximum-diameter measurement on adult CT images;...